Weekly shot aims to tame hunger and control weight in rare obesity disorders
NCT ID NCT06239116
Summary
This study is testing a new weekly injection called RM-718 to see if it is safe and can help control weight and hunger. It will involve about 150 people, including adults with general obesity and patients with obesity due to specific conditions like Prader-Willi Syndrome or brain injuries affecting the hypothalamus. The main goal is to check for side effects while also measuring changes in weight, body mass index, and hunger levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRADER-WILLI SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ann and Robert H. Lurie Children's Hospital of Chicago (Part C and Part D)
RECRUITINGChicago, Illinois, 60611, United States
-
Boston Children's Hospital (Part C only)
RECRUITINGBoston, Massachusetts, 021115, United States
-
Brigham and Women's Hospital (Part C and Part D)
RECRUITINGBoston, Massachusetts, 02115, United States
-
UAB Pediatric Endocrinology (Part C and Part D)
RECRUITINGBirmingham, Alabama, 35233, United States
-
University of Utah Pediatric Endocrine Clinic (Part C and Part D)
RECRUITINGSalt Lake City, Utah, 84112, United States
-
Vanderbilt University Medical Center (Part C only)
RECRUITINGNashville, Tennessee, 37232, United States
-
Worldwide Clinical Trials (Part A and Part B)
COMPLETEDSan Antonio, Texas, 78217, United States
Conditions
Explore the condition pages connected to this study.